Verified peer comparison
Surrozen vs CRISPR Therapeutics Financial Comparison
Direct answer
Surrozen and CRISPR Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Surrozen email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Surrozen Revenue
- 3,477,000 USD
- CRISPR Therapeutics Revenue
- 3,510,000 USD
- Surrozen Operating income
- -42,092,000 USD
- CRISPR Therapeutics Operating income
- -568,318,000 USD